| Useful Advices |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Workplace Communication > Resolving Team Conflict-Nine Steps to Constructive Resolution |
|
Useful Advices - Resolving Team Conflict-Nine Steps to Constructive Resolution
If you’ve ever worked on a team where one or more of the team members are in conflict, then you know just how stressful this situation can be. Left unresolved, conflicts between indi According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product viduals can fester, spill over into the team’s relationships, and seriously hinder productivity. What’s a team leader to do? Let’s begin with what not to do. Ignore It You ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in may have tried the avoidance technique thinking that the issue will just die down. And perhaps it did...temporarily. But the next time someone on the team experiences similar frustra lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. tions, that simmering pot will boil right over. Quash It This is my personal favorite: just demand that the folks in conflict grow up and get over it. Try this tactic and yo here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ’ll drive the conflict underground. That results in lots of game playing. I recall a team that I worked on early in my career that had one very unhappy team member and one manager wh d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro o insisted that she “get over it”. The rest of the team were treated to strange, stealth attacks in which nasty magazine articles mysteriously appeared on our desks, offering advice ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc about cheap nose jobs, eliminating bad breath, and improving personal hygiene. Tell Them to Work It Out On the surface this looks like a pretty good course of action: hold t easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi hem accountable and don’t get involved. Sweet. The problem is that if your team members could have worked it out without your help, they would have done that already. What they need nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically s your guidance to help talk it through and arrive at resolution. Take Sides It may seem like the quickest route to resolution is to intervene and crown the winner. There is and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ more than one problem with this approach. First, you remind them of Mom or Dad, so guess who they’ll come to when it’s time to find a judge for the next disagreement? Second, confli ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ct usually isn’t this clear cut. We bring the complexity of our life experiences to the table any time we find we are in conflict. Since these four approaches won’t work in the long ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a term, let’s look at some underlying principles: dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod n unreasonable demands.
cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin and expressed as fact.
tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen a neutral mediator. Try this approach the next time you have two people on your team in conflict:
t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel neutral facilitator.
ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust nding.
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products they learned that helps them understand the other’s point of view.
. As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de tion plan with small steps to success.
Eventually this process can be used by all team members when conflict arises. You won’t be elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip tempted to ignore it, quash it, tell them to work it out, or take sides. The team will experience the long-term gains of developing stronger, deeper relationships with your guidance tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:The Sometimes Life Of The Early-Stage, Mid-Stage And Even Late-Stage Entrepreneur Can Be Scattered To Raise Funds You Must Strategize
|